This why its up, nice news...Canadian biotech firm Tekmira Pharmaceuticals (TKMR)announced that the Federal Drug Administration knocked down a key barrier to its medicine, TKM Ebola, reaching some patients. The FDA moved the drug from a "full hold" to a "partial hold," which means Tekmira can use the drug in limited experiments.
News 
Market Data 
Discover 
